Chronic Pain (Anywhere)

Chronic Pain (Anywhere)

Chronic Pain (Anywhere)
Duration:
15 minutes

Cannabis has gained recognition as a potential therapy for managing chronic pain, offering relief through its interaction with the endocannabinoid system. Cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) bind to CB1 and CB2 receptors in the nervous system, reducing pain signals and inflammation (Fine & Rosenfeld, 2013). This mechanism is particularly beneficial for neuropathic pain, a condition resistant to conventional treatments.

Clinical studies have demonstrated that cannabis can significantly reduce pain intensity and improve sleep quality in patients with chronic pain (Ware et al., 2010). Its ability to lower reliance on opioids is another notable benefit, potentially mitigating the risks associated with long-term opioid use, such as dependency and overdose (Boehnke et al., 2016). Additionally, cannabis has shown efficacy in managing pain associated with conditions like fibromyalgia, arthritis, and multiple sclerosis, making it a versatile option for diverse chronic pain syndromes (Russo, 2008).

While cannabis holds promise, its use requires careful consideration of dosage and method of delivery to minimize side effects. Continued research is essential to refine its role in chronic pain management and establish standardized treatment protocols.

References

  1. Boehnke, K. F., Litinas, E., & Clauw, D. J. (2016). Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. The Journal of Pain, 17(6), 739-744.
  2. Fine, P. G., & Rosenfeld, M. J. (2013). The endocannabinoid system, cannabinoids, and pain. Rambam Maimonides Medical Journal, 4(4), e0022.
  3. Russo, E. B. (2008). Cannabinoids in the management of difficult to treat pain. Therapeutics and Clinical Risk Management, 4(1), 245-259.
  4. Ware, M. A., Wang, T., Shapiro, S., & Collet, J. P. (2010). Cannabis for the management of pain: assessment of safety study (COMPASS). The Journal of Pain, 11(12), 1233-1242.
  5. Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., & Kleijnen, J. (2015). Cannabinoids for medical use: a systematic review and meta-analysis. JAMA, 313(24), 2456-2473.

Get In Touch With Us

We're here to answer your questions, address your healthcare needs, and provide you with the support and guidance you deserve. Whether you're interested in our Functional Medicine services, have urgent care, IV therapy concerns, or simply want to connect with our dedicated team, we welcome your inquiries.

Contact Us